Range Low Price High Price Comment
30 days $20.00 $20.00 Wednesday, 15th Apr 2020 ARQL stock ended at $20.00. During the day the stock fluctuated 0% from a day low at $20.00 to a day high of $20.00.
90 days $20.00 $20.00
52 weeks $5.76 $20.45

Historical ArQule prices

Date Open High Low Close Volume
Nov 28, 2016 $1.40 $1.53 $1.40 $1.46 126 160
Nov 25, 2016 $1.39 $1.40 $1.34 $1.40 28 192
Nov 23, 2016 $1.36 $1.40 $1.32 $1.38 92 961
Nov 22, 2016 $1.36 $1.40 $1.35 $1.38 68 633
Nov 21, 2016 $1.40 $1.40 $1.31 $1.38 199 485
Nov 18, 2016 $1.40 $1.41 $1.36 $1.40 138 279
Nov 17, 2016 $1.38 $1.42 $1.30 $1.38 75 277
Nov 16, 2016 $1.38 $1.42 $1.30 $1.38 87 605
Nov 15, 2016 $1.40 $1.42 $1.27 $1.38 65 009
Nov 14, 2016 $1.39 $1.42 $1.36 $1.40 110 429
Nov 11, 2016 $1.38 $1.39 $1.34 $1.35 110 085
Nov 10, 2016 $1.37 $1.38 $1.30 $1.38 34 445
Nov 09, 2016 $1.30 $1.36 $1.30 $1.35 25 356
Nov 08, 2016 $1.31 $1.31 $1.31 $1.31 68 007
Nov 07, 2016 $1.22 $1.35 $1.21 $1.28 103 700
Nov 04, 2016 $1.24 $1.30 $1.21 $1.22 91 100
Nov 03, 2016 $1.21 $1.26 $1.21 $1.24 100 400
Nov 02, 2016 $1.26 $1.26 $1.20 $1.22 53 700
Nov 01, 2016 $1.34 $1.34 $1.22 $1.25 209 500
Oct 31, 2016 $1.35 $1.43 $1.33 $1.34 51 400
Oct 28, 2016 $1.38 $1.48 $1.32 $1.36 349 000
Oct 27, 2016 $1.43 $1.49 $1.38 $1.43 82 800
Oct 26, 2016 $1.40 $1.48 $1.38 $1.43 174 300
Oct 25, 2016 $1.43 $1.49 $1.40 $1.41 90 200
Oct 24, 2016 $1.49 $1.50 $1.42 $1.45 85 100
Click to get the best stock tips daily for free!

About ArQule

ArQule ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer and non-small cell lung cancer; Phase II clinical trial for the treatment of mesotheli... ARQL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT